Bladder Cancer is committed to the highest ethical standards and best practices in publishing and follows the code of conduct for Committee on Publication Ethics/DOAJ and the ICMJE. Any possible conflict of interest, financial or otherwise, of perceived relevance to the submitted work must be clearly indicated in the manuscript (for further details see http://www.icmje.org/icmje-recommendations.pdf).
Bladder Cancer affirms that misconduct, in the form of fabrication, falsification, or plagiarism, jeopardizes the success of the entire scientific endeavor. However, the primary responsibility for considering and resolving allegations of scientific misconduct must be pursued within the individual academic communities and institutions where the scientific work is carried out. Every author of articles or abstracts submitted for publication assumes full responsibility, within the limits of his or her professional competence, for the accuracy of the report. In the case of multiple-authored papers, each author should have made a significant intellectual or practical contribution to the scientific work. Authors submit articles with the understanding that reports must not have been submitted elsewhere.
Questions raised about the conduct of experiments or their presentation will be evaluated preliminarily by the Editors-in-Chief and, if appropriate, in consultation with the Associate Editor handling the review of the manuscript. If deemed appropriate, the matter will be referred to the institution where the scientific work in question was performed. The Journal expects that the matter would be reviewed in accordance with institutional procedures for handling allegations of misconduct. At all stages, every effort should be made to ensure that the process is fair and just, both for those who are accused of misconduct and for those who have raised the issue of scientific misconduct.
In the event that a published article or abstract is to be retracted, a statement of retraction will be published in Bladder Cancer.